PNC Financial Services Group’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.41K	Buy	1,869 +1,032	+123%	+$4.51K	﹤0.01%	4029
2025 Q4	$4.03K	Sell	837 -713	-46%	-$3.21K	﹤0.01%	4317
2025 Q3	$7.04K	Sell	1,550 -11	-0.7%	-$40	﹤0.01%	4073
2025 Q2	$4.82K	Sell	1,561 -5	-0.3%	-$17	﹤0.01%	4152
2025 Q1	$5.46K	Buy	1,566 +902	+136%	+$3.01K	﹤0.01%	4030
2024 Q4	$2.17K	Sell	664 -13	-2%	-$48	﹤0.01%	4261
2024 Q3	$2.61K	Buy	677 +13	+2%	+$50	﹤0.01%	4222
2024 Q2	$2.05K	Buy	664 +456	+219%	+$1.37K	﹤0.01%	4251
2024 Q1	$537	Hold	208	–	–	﹤0.01%	4486
2023 Q4	$520	Buy	+208	New	+$407	﹤0.01%	4409
2018 Q4	–	Sell	-28,188	Closed	-$266K	–	4017
2018 Q3	$266K	Sell	28,188 -39,417	-58%	-$391K	﹤0.01%	2038
2018 Q2	$493K	Buy	+67,605	New	+$402K	﹤0.01%	1656
2015 Q3	–	Sell	-400	Closed	-$5K	–	4603
2015 Q2	$5K	Hold	400	–	–	﹤0.01%	4058
2015 Q1	$7K	Sell	400 -500	-56%	-$10.2K	﹤0.01%	3906
2014 Q4	$14K	Sell	900 -10,500	-92%	-$181K	﹤0.01%	3258
2014 Q3	$240K	Buy	+11,400	New	+$186K	﹤0.01%	1882